In vitro susceptibilities of Mycoplasma genitalium to antibiotics.
作者信息
Renaudin H, Tully J G, Bebear C
机构信息
Laboratoire de Bactériologie, Hôpital Pellegrin, Bordeaux, France.
出版信息
Antimicrob Agents Chemother. 1992 Apr;36(4):870-2. doi: 10.1128/AAC.36.4.870.
Abstract
The susceptibilities of seven clinical isolates of Mycoplasma genitalium and three strains of Mycoplasma pneumoniae to a variety of antibiotics were examined by an agar dilution method. Macrolides, pristinamycin, and tetracyclines were very active against both species. Sparfloxacin was the most active quinolone tested. None of the 21 antibiotics tested had differential activity toward the two organisms.
摘要
相似文献
1
In vitro susceptibilities of Mycoplasma genitalium to antibiotics.
Antimicrob Agents Chemother. 1992 Apr;36(4):870-2. doi: 10.1128/AAC.36.4.870.
2
Comparative susceptibilities of various AIDS-associated and human urogenital tract mycoplasmas and strains of Mycoplasma pneumoniae to 10 classes of antimicrobial agent in vitro.
J Med Microbiol. 1998 Dec;47(12):1115-22. doi: 10.1099/00222615-47-12-1115.
3
Turning the Tide against Antibiotic Resistance by Evaluating Novel, Halogenated Phenazine, Quinoline, and NH125 Compounds against Species Clinical Isolates and Type Strains.
Antimicrob Agents Chemother. 2019 Feb 26;63(3). doi: 10.1128/AAC.02265-18. Print 2019 Mar.
4
[In vitro sensitivity to antibiotics in 178 strains of genital mycoplasma isolated from gynecology consultants in Dakar].
Bull Soc Pathol Exot. 2000 Feb;93(1):6-7.
5
Comparative potency of gemifloxacin, new quinolones, macrolides, tetracycline and clindamycin against Mycoplasma spp.
J Antimicrob Chemother. 2000 Apr;45 Suppl 1:29-33. doi: 10.1093/jac/45.suppl_3.29.
6
In vitro activity of several antimicrobial agents against genital mycoplasmas.
Clin Ther. 1992 Sep-Oct;14(5):688-95.
7
In-vitro activity of trospectomycin sulphate against Mycoplasma and Ureaplasma species isolated from humans.
J Antimicrob Chemother. 1988 Jun;21(6):731-6. doi: 10.1093/jac/21.6.731.
8
Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to a new quinolone, OPC 17116.
Antimicrob Agents Chemother. 1993 Aug;37(8):1726-7. doi: 10.1128/AAC.37.8.1726.
9
In vitro susceptibilities of Mycoplasma putrefaciens field isolates.
Antimicrob Agents Chemother. 2007 Sep;51(9):3452-4. doi: 10.1128/AAC.00420-07. Epub 2007 Jul 16.
10
Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones.
Antimicrob Agents Chemother. 2001 Sep;45(9):2604-8. doi: 10.1128/AAC.45.9.2604-2608.2001.
引用本文的文献
1
Sexually transmitted infections in Spain: Current status.
Rev Esp Quimioter. 2023 Oct;36(5):444-465. doi: 10.37201/req/038.2023. Epub 2023 Jun 19.
2
Use of Pristinamycin for Macrolide-Resistant Mycoplasma genitalium Infection.
Emerg Infect Dis. 2018 Feb;24(2):328-335. doi: 10.3201/eid2402.170902.
3
infections: current treatment options and resistance issues.
Infect Drug Resist. 2017 Sep 1;10:283-292. doi: 10.2147/IDR.S105469. eCollection 2017.
4
New Horizons in Mycoplasma genitalium Treatment.
J Infect Dis. 2017 Jul 15;216(suppl_2):S412-S419. doi: 10.1093/infdis/jix132.
5
Prevalence of macrolide and fluoroquinolone resistance-mediating mutations in Mycoplasma genitalium in five cities in Russia and Estonia.
PLoS One. 2017 Apr 13;12(4):e0175763. doi: 10.1371/journal.pone.0175763. eCollection 2017.
6
Management of Mycoplasma genitalium infections - can we hit a moving target?
BMC Infect Dis. 2015 Aug 19;15:343. doi: 10.1186/s12879-015-1041-6.
7
Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin.
BMC Infect Dis. 2015 Feb 3;15:40. doi: 10.1186/s12879-015-0781-7.
8
Mycoplasma genitalium: an emerging sexually transmitted pathogen.
Indian J Med Res. 2012 Dec;136(6):942-55.
9
Mycoplasma genitalium: should we treat and how?
Clin Infect Dis. 2011 Dec;53 Suppl 3(Suppl 3):S129-42. doi: 10.1093/cid/cir702.
10
Mycoplasma genitalium: from Chrysalis to multicolored butterfly.
Clin Microbiol Rev. 2011 Jul;24(3):498-514. doi: 10.1128/CMR.00006-11.
本文引用的文献
1
Urogenital mycoplasma infections of man: a review with observations on a recently discovered mycoplasma.
Isr J Med Sci. 1981 Jul;17(7):524-30.
2
The pathogenicity of a newly discovered human mycoplasma (strain G37) for the genital tract of marmosets.
J Hyg (Lond). 1982 Dec;89(3):449-55. doi: 10.1017/s0022172400071011.
3
Serological cross-reactions between Mycoplasma genitalium and Mycoplasma pneumoniae.
J Clin Microbiol. 1984 Dec;20(6):1036-43. doi: 10.1128/jcm.20.6.1036-1043.1984.
4
Microimmunofluorescence technique for detection of antibody to Mycoplasma genitalium.
J Clin Pathol. 1984 Sep;37(9):1072-4. doi: 10.1136/jcp.37.9.1072.
5
A newly discovered mycoplasma in the human urogenital tract.
Lancet. 1981 Jun 13;1(8233):1288-91. doi: 10.1016/s0140-6736(81)92461-2.
6
[Comparative activity of minocycline and doxycycline on mycoplasmas pathogenic for man].
Pathol Biol (Paris). 1985 Jun;33(5 Pt 2):577-80.
7
Urogenital challenge of primate species with Mycoplasma genitalium and characteristics of infection induced in chimpanzees.
J Infect Dis. 1986 Jun;153(6):1046-54. doi: 10.1093/infdis/153.6.1046.
8
Probable insensitivity of mollicutes to rifampin and characterization of spiroplasmal DNA-dependent RNA polymerase.
J Bacteriol. 1986 Jun;166(3):824-8. doi: 10.1128/jb.166.3.824-828.1986.
9
Isolation and characterization of Mycoplasma genitalium strains from the human respiratory tract.
J Clin Microbiol. 1988 Nov;26(11):2266-9. doi: 10.1128/jcm.26.11.2266-2269.1988.
10
Non-occurrence of Mycoplasma genitalium in clinical specimens.
Eur J Clin Microbiol Infect Dis. 1988 Feb;7(1):49-51. doi: 10.1007/BF01962172.
Zotero 插件